Exciting times ahead for biomedical sector in Malaysia


PHILADELPHIA: Exciting times are ahead for Malaysia when one of the top Asian biopharmaceutical giants Biocon Ltd begins operations in the country next year.

Malaysia Biotechnology Corp (Biotech Corp) biomedical section senior vice-president Jay Padasian said it had taken about two years to convince the company to set up its integrated insulin plant in Malaysia.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

News , bureaus , biomedical , malaysia ,

   

Next In Business News

FBM KLCI continues rebound after two days of recovery
Trading ideas: RHB, Axiata, Yinson, Affin, Kimlun, AWC, Pansar, DC Healthcare, AwanBiru, Systech, Auro, Bursa Malaysia, HeiTech Padu, AmFirst REIT and Sin-Kung Logistics
EPF Account 3 draws concerns over dividends
Developers gearing up for higher sales
Kimlun wins RM150mil deal from Astaka
Systech gets shareholders’ nod for capital exercise
Huawei starts new smartphone Pura 70 sale amid scrutiny on chips
Smart Asia en route for listing on ACE Market
IGB-REIT likely to maintain organic growth
State-owned enterprises achieve milestone in key HSR construction

Others Also Read